Rho GAP p190B inhibitors are a class of chemical compounds that specifically target and inhibit the function of p190B, a Rho GTPase-activating protein (GAP). p190B functions as a key regulator of Rho GTPases, a family of molecular switches that control essential cellular processes such as cytoskeletal organization, cell migration, and proliferation. Rho GTPases cycle between an active GTP-bound state and an inactive GDP-bound state, and Rho GAPs like p190B accelerate the hydrolysis of GTP to GDP, promoting the inactivation of Rho GTPases. By inhibiting p190B, these compounds prevent the GAP-mediated inactivation of Rho GTPases, allowing them to remain in their active, GTP-bound form for a longer period. This can lead to prolonged signaling through Rho GTPase pathways, influencing various cellular behaviors dependent on Rho GTPase activity.
The inhibition of p190B can result in significant changes in cellular processes, particularly those that involve the actin cytoskeleton and cell movement, as Rho GTPases play a central role in these functions. By preventing the inactivation of Rho GTPases, p190B inhibitors disrupt the delicate balance between activation and inactivation, potentially leading to enhanced or dysregulated cell migration, adhesion, and shape changes. Researchers use p190B inhibitors to explore the specific contributions of Rho GTPase signaling to cellular dynamics and how the regulation of these pathways influences developmental and physiological processes. These inhibitors serve as valuable tools for understanding the role of Rho GAPs in cellular signaling networks, revealing how proteins like p190B coordinate complex processes such as cytoskeletal remodeling and cell polarity. Furthermore, the study of p190B inhibitors offers insights into the broader regulation of GTPase signaling, helping to uncover the mechanisms that govern cellular responses to environmental stimuli and intracellular signals. Through these studies, scientists gain a deeper understanding of the molecular control of Rho GTPase activity and its impact on cell function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, may downregulate Rho GAP p190B by remodeling chromatin to silence its gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could reduce Rho GAP p190B expression by DNA demethylation, thus disrupting transcriptional silencing. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 may decrease Rho GAP p190B expression by inhibiting DNA methyltransferase activity, leading to gene reactivation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
This MEK inhibitor could downregulate Rho GAP p190B by hindering the ERK pathway, which is responsible for gene transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002 may decrease Rho GAP p190B expression by blocking PI3K, leading to a reduction in transcriptional activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin could reduce Rho GAP p190B synthesis by inhibiting mTOR, a key regulator of protein translation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 may downregulate Rho GAP p190B by impeding MEK1/2, thereby decreasing activation of transcription factors for the gene. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 could inhibit Rho GAP p190B expression by obstructing JNK activity, which is necessary for certain gene expressions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB 203580 might decrease Rho GAP p190B expression by targeting p38 MAPK, which can control transcriptional responses. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 could lead to the downregulation of Rho GAP p190B by inhibiting ROCK, which plays a role in gene expression pathways. | ||||||